TUV Rheinland, State ink pact

Medical devices testing lab to be set up in MedTech Zone

June 17, 2017 01:17 am | Updated 01:17 am IST - VISAKHAPATNAM

The Medical Devices Park that is coming up in the district will have about 250-300 medical devices manufacturing units, according to Jitendra Kumar Sharma, CEO of Andhra Pradesh MedTech Zone (AMTZ).

He was speaking at the signing of an MoU between the State government and TUV Rheinland (India) Private Limited, an Indian subsidiary of the German firm, here on Friday.

“There is immense potential for import substitution, and at a later stage for exports also, of medical devices in India as 80% of the devices are being imported at present, said Thomas Fuhrmann, CEO and MD of TUV Rheinland (India) Private Limited. TUV will be setting up a medical devices testing lab in the Medical Devices Park, which is coming up in an extent of 270 acres. Mr. Fuhrmann further said his company had been awarded the contract to set up and operate the laboratory with facilities for testing electro-magnetic interference (EMI/EMC), anechoic chambers, bio-material reliability and electrical safety. “The State government would provide the land, two acres or so, in the park and we have to invest roughly about ₹100 crore on the lab,” he said.

He also lauded the efforts of the State government in setting up the park, which would give a great boost to the sector in the State and in the country.

Advantages

Vice-president of the company Kalyan Verma said: “Availability of world-class testing facilities within the Medical Devices Park will make it easier for the manufacturers to improve quality. It will reduce logistics cost and the manufacturers can get their products tested within the park in accordance with the new Medical Devices Rules, 2017, coming into force from January 1, 2018.” The testing lab would be ready by next year.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.